Combination of MRI and dynamic FET PET for initial glioma grading.


Autoria(s): Dunet V.; Maeder P.; Nicod-Lalonde M.; Lhermitte B.; Pollo C.; Bloch J.; Stupp R.; Meuli R.; Prior J.O.
Data(s)

2014

Resumo

AIM: MRI and PET with 18F-fluoro-ethyl-tyrosine (FET) have been increasingly used to evaluate patients with gliomas. Our purpose was to assess the additive value of MR spectroscopy (MRS), diffusion imaging and dynamic FET-PET for glioma grading. PATIENTS, METHODS: 38 patients (42 ± 15 aged, F/M: 0.46) with untreated histologically proven brain gliomas were included. All underwent conventional MRI, MRS, diffusion sequences, and FET-PET within 3±4 weeks. Performances of tumour FET time-activity-curve, early-to-middle SUVmax ratio, choline / creatine ratio and ADC histogram distribution pattern for gliomas grading were assessed, as compared to histology. Combination of these parameters and respective odds were also evaluated. RESULTS: Tumour time-activity-curve reached the best accuracy (67%) when taken alone to distinguish between low and high-grade gliomas, followed by ADC histogram analysis (65%). Combination of time-activity-curve and ADC histogram analysis improved the sensitivity from 67% to 86% and the specificity from 63-67% to 100% (p < 0.008). On multivariate logistic regression analysis, negative slope of the tumour FET time-activity-curve however remains the best predictor of high-grade glioma (odds 7.6, SE 6.8, p = 0.022). CONCLUSION: Combination of dynamic FET-PET and diffusion MRI reached good performance for gliomas grading. The use of FET-PET/MR may be highly relevant in the initial assessment of primary brain tumours.

Identificador

http://serval.unil.ch/?id=serval:BIB_9520FD8C40F7

isbn:0029-5566 (Print)

pmid:24737132

doi:10.3413/Nukmed-0650-14-03

Idioma(s)

en

Fonte

Nuklearmedizin. Nuclear Medicine, vol. 53, no. 4, pp. 155-161

Tipo

info:eu-repo/semantics/article

article